RxDoctor Payments Data

Islam Shahin, MD

Vascular & Interventional Radiology · Desoto, TXNPI 1720042070

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $57,500 of the $72,135 with a category attached, or 79.7%. Sirtex Medical Inc accounts for 93.5% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2020 at $31,911 and has fallen 98.0% since, to $636 in 2025. Among vascular & interventional radiology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$72,135in general payments, 2019–2025

Across 267 payments — averaging $270.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sirtex Medical Inc$67K
  • Medtronic$897
  • Balt USA, LLC$827
  • Boston Scientific$733
  • Inari Medical, Inc.$472
  • Stryker$444
  • plus $1K from 17 others
$11,725in research payments, 2019–2025

Across 62 payments — averaging $189.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sirtex Medical Inc$12K

What the payments were for

  • Consulting fees$5,2907%
  • Speaking & faculty fees$57,50080%
  • Travel & lodging$2,8454%
  • Food & beverage$6,5009%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$72,135 in reported general payments places this provider in the 90th percentile of 299 vascular & interventional radiology providers in Texas.

See all vascular & interventional radiology providers in Texas

Medicare billing

Part B allowed, 2024
$85,210
Medicare patients
161
Services billed
849

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sucralfate29$559
Methylprednisolone28$250
Omeprazole24$216

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Desoto

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →